Urinary anatalline and nicotelline cut-points to distinguish between exclusive and dual use of tobacco products.

References

• Benowitz NL, Bernert JT, Foulds J, et al. Biochemical Verification of Tobacco Use and Abstinence: 2019 Update. Nicotine Tob Res. Jun 12 2020;22(7):1086-1097. doi: 10.1093/ntr/ntz132
   Google Scholar
• Tompkins EL, Beltran TA, Bedno SA. Differentiating between smokers and nonsmokers using serum cotinine. Biomark Med. Aug 2019;13(12):1025-1033. doi: 10.2217/bmm-2019-0027
   Google Scholar
• Edwards KC, Naz T, Stanton CA, et al. Urinary Cotinine and Cotinine + Trans-3'-Hydroxycotinine (TNE-2) Cut-points for Distinguishing Tobacco Use from Nonuse in the United States: PATH Study (2013-2014). Cancer Epidemiol Biomarkers Prev. Jun 2021;30(6):1175-1184. doi: 10.1158/1055-9965.Epi-20-0997
   Google Scholar
• Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol. Jan 15 2009;169(2):236-48. doi: 10.1093/aje/kwn301
   Google Scholar
• Mourino N, Pérez-Ríos M, Santiago-Pérez MI, Lanphear B, Yolton K, Braun JM. Secondhand tobacco smoke exposure among children under 5 years old: questionnaires versus cotinine biomarkers: a cohort study. BMJ Open. Jun 28 2021;11(6):e044829. doi: 10.1136/bmjopen-2020-044829
   Google Scholar
• Jacob P, Chan L, Cheung P, et al. Minor Tobacco Alkaloids as Biomarkers to Distinguish Combusted Tobacco Use From Electronic Nicotine Delivery Systems Use. Two New Analytical Methods. Front Chem. 2022;10:749089. doi: 10.3389/fchem.2022.749089
   Google Scholar
• Goniewicz ML, Smith DM. Are Some E-Cigarette Users "Blowing Smoke"?: Assessing the Accuracy of Self-Reported Smoking Abstinence in Exclusive E-Cigarette Users. Nicotine Tob Res. Apr 17 2019;21(5):699-700. doi: 10.1093/ntr/nty085
   Google Scholar
• Prevention CfDCa. Smokeless Tobacco Product Use in the United States. Accessed July 16, 2024. https://www.cdc.gov/tobacco/other-tobacco-products/smokeless-product-use-in-the-us.html#:∼:text=About%202%20in%20every%20100%20%282.1%25%29%20adults%20aged,every%20100%20%284.2%25%29%20men%20currently%20used%20smokeless%20tobacco.
   Google Scholar
• Norris TA-G, D., Bottoms-McClain, L. Early Release of Selected Estimates Based on Data From the 2023 National Health Interview Survey. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. Accessed July 16, 2024. https://www.cdc.gov/nchs/data/nhis/earlyrelease/earlyrelease202405.pdf
   Google Scholar
• United States Department of Health and Human Services NIoH, National Institute on Drug Abuse, and United States Department of Health and Human Services, Food and Drug Adminstration, Center for Tobacco Products. . PATH Study Data Tables and Figures: Waves 1-5 (2013-2019). Inter-university Consortium for Political and Social Research [distributor]. Accessed May 23, 2024.
   Google Scholar
• Hirschtick JL, Mattingly DT, Cho B, et al. Exclusive, Dual, and Polytobacco Use Among US Adults by Sociodemographic Factors: Results From 3 Nationally Representative Surveys. American Journal of Health Promotion. 2021;35(3):377-387. doi: 10.1177/0890117120964065
   Google Scholar
• Jacob P, 3rd, Yu L, Shulgin AT, Benowitz NL. Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes. Am J Public Health. May 1999;89(5):731-6. doi: 10.2105/ajph.89.5.731
   Google Scholar
• Jacob P, St Helen G, Yu L, et al. Biomarkers of Exposure for Dual Use of Electronic Cigarettes and Combustible Cigarettes: Nicotelline, NNAL, and Total Nicotine Equivalents. Nicotine Tob Res. Jun 12 2020;22(7):1107-1113. doi: 10.1093/ntr/ntz235
   Google Scholar
• United States Department of Health and Human Services, Food and Drug Adminstration. Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke: Established List. Accessed May 23, 2024. https://www.fda.gov/tobacco-products/rules-regulations-and-guidance/harmful-and-potentially-harmful-constituents-tobacco-products-and-tobacco-smoke-established-list
   Google Scholar
• Xia B, Blount BC, Guillot T, et al. Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014). Nicotine Tob Res. Feb 16 2021;23(3):573-583. doi: 10.1093/ntr/ntaa110
   Google Scholar
• Choi K, Sabado M, El-Toukhy S, Vogtmann E, Freedman ND, Hatsukami D. Tobacco Product Use Patterns, and Nicotine and Tobacco-Specific Nitrosamine Exposure: NHANES 1999-2012. Cancer Epidemiol Biomarkers Prev. Oct 2017;26(10):1525-1530. doi: 10.1158/1055-9965.Epi-17-0338
   Google Scholar
• De Jesús VR, Bhandari D, Zhang L, et al. Urinary Biomarkers of Exposure to Volatile Organic Compounds from the Population Assessment of Tobacco and Health Study Wave 1 (2013-2014). Int J Environ Res Public Health. Jul 28 2020;17(15) doi: 10.3390/ijerph17155408
   Google Scholar
• Chambers DM, Ocariz JM, McGuirk MF, Blount BC. Impact of cigarette smoking on volatile organic compound (VOC) blood levels in the U.S. population: NHANES 2003-2004. Environ Int. Nov 2011;37(8):1321-8. doi: 10.1016/j.envint.2011.05.016
   Google Scholar
• Chaffee BW, Jacob P, Couch ET, Benowitz NL. Exposure to a Tobacco-Specific Carcinogen Among Adolescent Smokeless Tobacco Users in Rural California, United States. Nicotine Tob Res. Oct 8 2020;22(10):1764-1771. doi: 10.1093/ntr/ntz147
   Google Scholar
• Cheng YC, Reyes-Guzman CM, Christensen CH, et al. Biomarkers of Exposure among Adult Smokeless Tobacco Users in the Population Assessment of Tobacco and Health Study (Wave 1, 2013-2014). Cancer Epidemiol Biomarkers Prev. Mar 2020;29(3):659-667. doi: 10.1158/1055-9965.Epi-19-0766
   Google Scholar
• Akiyama Y, Sherwood N. Systematic review of biomarker findings from clinical studies of electronic cigarettes and heated tobacco products. Toxicol Rep. 2021;8:282-294. doi: 10.1016/j.toxrep.2021.01.014
   Google Scholar
• Goniewicz ML, Smith DM, Edwards KC, et al. Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes. JAMA Netw Open. Dec 7 2018;1(8):e185937. doi: 10.1001/jamanetworkopen.2018.5937
   Google Scholar
• Dai H, Benowitz NL, Achutan C, Farazi PA, Degarege A, Khan AS. Exposure to Toxicants Associated With Use and Transitions Between Cigarettes, e-Cigarettes, and No Tobacco. JAMA Netw Open. Feb 1 2022;5(2):e2147891. doi: 10.1001/jamanetworkopen.2021.47891
   Google Scholar
• David E, Niculescu V-C. Volatile Organic Compounds (VOCs) as Environmental Pollutants: Occurrence and Mitigation Using Nanomaterials. International Journal of Environmental Research and Public Health. 2021;18(24):13147.
   Google Scholar
• Jacob P, 3rd, Goniewicz ML, Havel CM, Schick SF, Benowitz NL. Nicotelline: a proposed biomarker and environmental tracer for particulate matter derived from tobacco smoke. Chem Res Toxicol. Nov 18 2013;26(11):1615-31. doi: 10.1021/tx400094y
   Google Scholar
• Chang CM, Edwards SH, Arab A, Del Valle-Pinero AY, Yang L, Hatsukami DK. Biomarkers of Tobacco Exposure: Summary of an FDA-Sponsored Public Workshop. Cancer Epidemiol Biomarkers Prev. Mar 2017;26(3):291-302. doi: 10.1158/1055-9965Epi-16-0675
   Google Scholar
• Klemperer EM, Kock L, Feinstein MJP, Coleman SRM, Gaalema DE, Higgins ST. Sex differences in tobacco use, attempts to quit smoking, and cessation among dual users of cigarettes and e-cigarettes: Longitudinal findings from the US Population Assessment of Tobacco and Health Study. Prev Med. Jun 6 2024;185:108024. doi: 10.1016/j.ypmed.2024.108024
   Google Scholar
• Feng J, Sosnoff CS, Bernert JT, et al. Urinary Nicotine Metabolites and Self-Reported Tobacco Use Among Adults in the Population Assessment of Tobacco and Health (PATH) Study, 2013-2014. Nicotine Tob Res. Mar 26 2022;24(5):768-777. doi: 10.1093/ntr/ntab206
   Google Scholar
• United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse, and United States Department of Health and Human Services. Food and Drug Administration. Center for Tobacco Products.. Population Assessment of Tobacco and Health (PATH) Study [United States] Biomarker Restricted-Use Files. 2024-06-14. doi: 10.3886/ICPSR36840.v21
   Google Scholar
• United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse, and United States Department of Health and Human Services. Food and Drug Administration. Center for Tobacco Products.. Population Assessment of Tobacco and Health (PATH) Study [United States] Urinary Nicotine Metabolites and Analogs Laboratory Panel Documentation. Inter-university Consortium for Political and Social Research [distributor]2024. doi: 10.3886/ICPSR36840.v21
   Google Scholar
• United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse, and United States Department of Health and Human Services. Food and Drug Administration. Center for Tobacco Products.. Population Assessment of Tobacco and Health (PATH) Study [United States] Tobacco-specific Nitrosamines (TSNAs) Laboratory Panel Documentation. Inter-university Consortium for Political and Social Research [distributor]2024. doi: 10.3886/ICPSR36840.v21
   Google Scholar
• Hornung RW, Reed LD. Estimation of Average Concentration in the Presence of Nondetectable Values. Applied Occupational and Environmental Hygiene. 1990/01/01 1990;5(1):46-51. doi: 10.1080/1047322X.1990.10389587
   Google Scholar
• United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse, and United States Department of Health and Human Services. Food and Drug Administration. Center for Tobacco Products. Population Assessment of Tobacco and Health (PATH) Study [United States] Restricted-Use Files User Guide. Accessed on July 6, 2024. Population Assessment of Tobacco and Health (PATH) Study [United States] Restricted-Use Files User Guide (umich.edu)
   Google Scholar
• Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. Mar 2014;23(2):133-9. doi: 10.1136/tobaccocontrol-2012-050859
   Google Scholar
• Borland R, Murray K, Gravely S, et al. A new classification system for describing concurrent use of nicotine vaping products alongside cigarettes (so-called 'dual use'): findings from the ITC-4 Country Smoking and Vaping wave 1 Survey. Addiction. Oct 2019;114 Suppl 1(Suppl 1):24-34. doi: 10.1111/add.14570
   Google Scholar
• Chenoweth MJ, Cox LS, Nollen NL, et al. Analyses of nicotine metabolism biomarker genetics stratified by sex in African and European Americans. Scientific Reports. 2021/10/01 2021;11(1):19572. doi: 10.1038/s41598-021-98883-z
   Google Scholar
• Ross KC, Gubner NR, Tyndale RF, et al. Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking. Pharmacol Biochem Behav. Sep 2016;148:1-7. doi: 10.1016/j.pbb.2016.05.002
   Google Scholar